Update on infantile hemangiomas

Semin Perinatol. 2013 Feb;37(1):49-58. doi: 10.1053/j.semperi.2012.11.003.

Abstract

Infantile hemangiomas are the most common tumors of infancy. The serendipitous discovery of the therapeutic efficacy of propranolol in the management of infantile hemangiomas has revolutionized the care and understanding of these lesions, and greatly improved the prognosis for a good cosmetic outcome. In addition, there has been an expansion of indications for treatment of hemangiomas, taking into account not only those hemangiomas that can cause airway compromise, amblyopia, and cardiac overload, but also those lesions that can lead to unsatisfactory cosmetic outcome or deformity after involution. Current concepts of pathogenesis of infantile hemangiomas, of segmental hemangiomas with systemic associations, of hepatic hemangiomas, and of the use of systemic and topical beta-blockers for the management of IH are all reviewed.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage*
  • Female
  • Hemangioma, Capillary / diagnosis*
  • Hemangioma, Capillary / drug therapy
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Neoplastic Syndromes, Hereditary / diagnosis
  • Prognosis
  • Propranolol / administration & dosage*
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / drug therapy
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Propranolol

Supplementary concepts

  • Hemangioma, capillary infantile